7201 - 7225 of 8808 Results
Title
Year
-
OPENTitle: Modelling cholinergic and dopaminergic function over time in Parkinson’s disease with and without GBA1 variantsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41531-025-01160-3Best OA location URL: https://doi.org/10.1038/s41531-025-01160-3Citation Count: 0
-
OPENTitle: Functional network differences between unilateral and bilateral deep brain stimulation of the subthalamic nucleusJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-025-01064-2Best OA location URL: https://doi.org/10.1038/s41531-025-01064-2Citation Count: 0
- Chronic Pain in Parkinson’s Disease: Prevalence, Sex Differences, Regional Anatomy and Comorbidities2025OPENTitle: Chronic Pain in Parkinson’s Disease: Prevalence, Sex Differences, Regional Anatomy and ComorbiditiesJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.70174Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.70174Citation Count: 0
-
RESTRICTEDTitle: Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 2Start Page: 145End Page: 154Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30405-8Citation Count: 111
-
OPENTitle: Genetic Modifiers of Parkinson's Disease: A Case–Control StudyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.70176Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.70176Citation Count: 0
-
OPENTitle: Generation of two human induced pluripotent stem cell lines from fibroblasts of Parkinson’s disease patients carrying the ILE368ASN mutation in PINK1 (LCSBi002) and the R275W mutation in Parkin (LCSBI004)Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 61Issue #:Start Page: 102765End Page: 102765Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2022.102765Best OA location URL: https://doi.org/10.1016/j.scr.2022.102765Citation Count: 3
-
RESTRICTEDTitle: Minimal change multiple system atrophy: An aggressive variant?Journal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 960End Page: 967Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26220Citation Count: 50
-
OPENTitle: Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00451-xBest OA location URL: https://www.nature.com/articles/s41531-023-00451-x.pdfCitation Count: 10
-
OPENTitle: Exploring the Interactions between two Ligands, UCB-J and UCB-F, and Synaptic Vesicle Glycoprotein 2 IsoformsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 15Issue #: 10Start Page: 2018End Page: 2027Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.4c00029Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.4c00029Citation Count: 1
-
OPENTitle: Intracellular delivery of Parkin-RING0-based fragments corrects Parkin-induced mitochondrial dysfunction through interaction with SLP-2Journal Name: Journal of Translational MedicinePublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12967-024-04850-3Best OA location URL: https://translational-medicine.biomedcentral.com/counter/pdf/10.1186/s12967-024-04850-3Citation Count: 2
-
RESTRICTEDTitle: Distinct Missense Mutations of the Parkinson's Disease‐Related Ubiquitin Kinase PINK1 Alter Auto‐ or Substrate‐PhosphorylationJournal Name: The FASEB JournalPublisher: WileyVol: 33Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fasebj.2019.33.1_supplement.lb329Citation Count: 0
-
OPENTitle: A cholinergic contribution to postural control and freezing of gait in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 8Start Page: 3110End Page: 3111Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awad223Best OA location URL: https://academic.oup.com/brain/article-pdf/146/8/3110/51018614/awad223.pdfCitation Count: 0
-
OPENTitle: Role of alpha-synuclein seed amplification assay in Parkinson’s disease clinical trials: A case of misdiagnosisJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 11Issue #:Start Page: 100274End Page: 100274Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100274Best OA location URL: https://doi.org/10.1016/j.prdoa.2024.100274Citation Count: 0
-
RESTRICTEDTitle: Pharmacodynamic, pharmacokinetic and rat brain receptor occupancy profile of NLX-112, a highly selective 5-HT1A receptor biased agonistJournal Name: Naunyn-Schmiedeberg's Archives of PharmacologyPublisher: Springer Science and Business Media LLCVol: 398Issue #: 1Start Page: 991End Page: 1002Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00210-024-03323-0Best OA location URL: https://hal.science/hal-04932477Citation Count: 1
-
OPENTitle: Increased odds of bladder and bowel symptoms in early Parkinson's diseaseJournal Name: Neurourology and UrodynamicsPublisher: WileyVol: 37Issue #: 4Start Page: 1344End Page: 1348Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/nau.23443Best OA location URL: http://doi.org/10.1002/nau.23443Citation Count: 10
-
OPENTitle: A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10G>T at the intron 9/exon 10 of the MAPT geneJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 106Issue #:Start Page: 343.e1End Page: 343.e8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.05.010Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2021.05.010Citation Count: 6
-
OPENTitle: TMEM230 in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 56Issue #:Start Page: 212.e1End Page: 212.e3Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2017.03.014Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5526081Citation Count: 8
-
OPENTitle: Effect of the mGlu2 receptor positive allosteric modulator AZD8529 on L-DOPA-induced dyskinesia and psychosis-like behaviours in the parkinsonian marmosetJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 1005Issue #:Start Page: 178031End Page: 178031Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ejphar.2025.178031Best OA location URL: https://doi.org/10.1016/j.ejphar.2025.178031Citation Count: 0
-
OPENTitle: Neurosurgeons perspective on the shift towards earlier use of deep brain stimulation for Parkinson diseaseJournal Name: Interdisciplinary NeurosurgeryPublisher: Elsevier BVVol: 25Issue #:Start Page: 101224End Page: 101224Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.inat.2021.101224Best OA location URL: https://doi.org/10.1016/j.inat.2021.101224Citation Count: 2
-
RESTRICTEDTitle: Serotonergic mediated body mass index changes in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 43Issue #: 3Start Page: 609End Page: 615Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2011.05.009Citation Count: 43
-
RESTRICTEDTitle: Recurrent neurologic symptoms complicating venom immunotherapy in a patient with systemic mastocytosis and severe Hymenoptera allergyJournal Name: The Journal of Allergy and Clinical Immunology: In PracticePublisher: Elsevier BVVol: 8Issue #: 2Start Page: 780End Page: 782Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jaip.2019.07.040Citation Count: 1
-
RESTRICTEDTitle: Susceptibility Magnetic Resonance Imaging Correlates with Glial Density and Tau in the Substantia Nigra Pars CompactaJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 3Start Page: 464End Page: 473Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29311Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10445152/pdf/nihms-1919028.pdfCitation Count: 9
-
RESTRICTEDTitle: Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson’s Disease and Their First-Degree Unaffected RelativesJournal Name: Brain TopographyPublisher: Springer Science and Business Media LLCVol: 31Issue #: 6Start Page: 1029End Page: 1036Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10548-018-0653-8Citation Count: 27
-
OPENTitle: Replication of a Novel Parkinson's Locus in a European Ancestry PopulationJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1689End Page: 1695Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28546Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28546Citation Count: 17
-
RESTRICTEDTitle: Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐lesioned primate model of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 772End Page: 779Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25859Citation Count: 39